121. Artday Network - Art BLog Cerebral thrombosis is more commonly known as a stroke. A stroke that damagessome part of Some people have a permanent injury by Cerebral thrombosis. http://artday.org/modules/weblog/details.php?blog_id=11

122. Fact Sheet No. 39 - March 2001 Deep Vein Thrombosis (DVT) And Long Distance Air Comcare OHS Fact Sheet No. 39 March 2001. Deep Vein thrombosis (DVT) and LongDistance Air Travel. Advice to Employers http://www.comcare.gov.au/publications/factsheets/fact-sheet-39.html

Comcare OHS Fact Sheet No. 39 - March 2001 Deep Vein Thrombosis (DVT) and Long Distance Air Travel Advice to Employers Comcare has had a number of enquiries from Commonwealth Agencies on the subject of DVT . Where employees regularly undertake long distance air travel, Agencies may need to undertake a risk analysis to determine the risk of exposure to employees having regard to the best medical data available. Further assessments may be required as medical knowledge develops and becomes clearer. Current medical information on DVT should be made available to all employees planning to travel by air. This will enable employees to be better informed and able to recognise potential problems or know to consult their doctor before travelling by air. What is DVT DVT is a blood clot, which develops in the veins of the leg. The clot may break off and travel through the blood stream and lodge in the brain, lungs, heart or other area causing severe damage to the organ concerned. DVT and Long Distance Air Travel Current medical evidence suggests long distance air travel may contribute to the development of DVT . This is not a new problem but recent publicity about the "Economy Class Syndrome" and the death of a number of long distance travellers from DVT

123. Phlebitis And Thrombosis: Health Topics: UI Health Care thrombosis is the formation of a blood clot that may partially or completely block a Healthy lifestyle habits can help prevent phlebitis and thrombosis. http://www.uihealthcare.com/topics/bloodandcirculatory/bloo4215.html

Health Topics Category Index Health Topics for Blood and Circulatory Blood Donation Pathology at UIHC Send comments and questions to staff@uihealthcare.com University of Iowa, Iowa City, Iowa Phlebitis And Thrombosis Phlebitis is an inflammation of a vein. Thrombosis is the formation of a blood clot that may partially or completely block a blood vessel. A clot located in an inflamed, blood vessel is called thrombophlebitis. A clot formation in a deeper vein is called a deep vein thrombosis. Blood clots may follow injury, surgery, childbirth, or prolonged bed rest. They may also be associated with infection. Symptoms of phlebitis may include: a hard and cord-like vein that is very sensitive to pressure or touch a surrounding area that is red and warm to the touch a slight fever or swelling of the extremity The primary danger in thrombophlebitis is that the clot may move and travel to a vital organ, such as the lung, causing serious damage. If you have symptoms of thrombophlebitis or deep vein thrombosis your healthcare provider may order a doppler ultrasound examination (a test that uses sound waves to locate clots); a venogram in which dye is injected into a vein, usually in the foot. (X-rays are then taken to visualize the circulation and any blockages that may be present.) Lung scans may be ordered if there is concern that blood clots have traveled to the lungs. Thrombosis is treated with anticoagulant drugs, such as heparin or coumadin. These drugs inhibit the formation of blood clots.

124. SPINALCORD: Deep Vein Thrombosis deep vein thrombosis. Prevention of Thromboembolism in Spinal Cord Injury, 2ndEd Published by Paralyzed Veterans of America http://www.spinalcord.uab.edu/show.asp?durki=21454&site=1021&return=21390

125. CNN.com - Deep Vein Thrombosis Explained - February 5, 2001 A thrombosis is the formation of a blood clot in a blood vessel. Deep veinthrombosis (DVT) is a form of thrombosis that develops in one of the deep veins http://edition.cnn.com/2001/WORLD/asiapcf/01/24/dvt.medical/

MAINPAGE ASIA WORLD WEATHER ... ABOUT US CNN TV How to get CNN TV what's on show transcripts CNN International EDITIONS CNN.com U.S. CNN.com Europe set your edition Languages Spanish Portuguese German Italian Danish Japanese Korean Arabic Time, Inc. Time.com People Fortune EW SERVICES E-MAIL SERVICES CNN MOBILE CNN AVANT GO DESKTOP TICKER ... AD INFO CNN TV what's on biz international inside sailing the music room ... CNN Partner Hotels EDITIONS CNN.com U.S. CNN.com Asia CNNArabic.com set your edition Languages Arabic Japanese Spanish Portuguese German Italian Korean Time, Inc. Time.com People Fortune EW Deep vein thrombosis explained By Andrew Demaria CNN.com writer A thrombosis is the formation of a blood clot in a blood vessel. Deep vein thrombosis (DVT) is a form of thrombosis that develops in one of the deep veins of the body. DVT often begins in the calf or thigh because blood moves relatively slowly in these areas, particularly if exercise is limited. As the blood begins to pool in an area, a clot develops and can attach itself to the wall of a vessel or in more severe cases become wedged within a vessel, blocking blood flow. Blood clots are common. And while a blood clot itself is not life threatening it can cause serious complications. Professor Reginald Lord, head of the vascular group of St. Vincent's hospital in Sydney, says only one percent of venous thromboses cause complications.

126. The Cardiovascular Thrombosis Research Center - UMass Medical School Welcome to the Cardiovascular thrombosis Research Center, University of MassachusettsMedical School. The TRC, established in 1987, includes several http://www.umassmed.edu/thrombosis/

directory contacts index this section only Home Anticoagulation Services Information Zone Clinicians/Clinician Scientists, Investigators ... thrombosis Cardiovascular Thrombosis Research Center About Us Welcome to the Cardiovascular Thrombosis Research Center, University of Massachusetts Medical School. The TRC, established in 1987, includes several distinct but integrated sections. Clinical Trials Epidemiology and Outcomes-based Research Laboratory for Vascular Biology Anticoagulation Services/Center for Patient-Empowering Therapeutics Thrombophillia Center Each section contributes to the TRC's stated primary goal of understanding the pathobiology, diagnosis and management of thrombotic disorders of the venous and arterial circulatory systems. The staff that includes physicians, nurses, advanced practice nurses, pharmacists, social workers, technicians and educators is committed to raising the standard of patient care through scientific investigation, education, and evidence-based clinical practice. Director: Richard C. Becker

127. New Thrombosis Drug Is Less Effective And More Expensive Than The Existing Drug A new drug used for the treatment of Essential Thrombocythemia (ET) is lesseffective and more expensive than the drug it is designed to replace, http://www.medicalnewstoday.com/medicalnews.php?newsid=27497

128. Diagnosis And Treatment Of Deep Venous Thrombosis And Pulmonary Embolism: Clinic Venous thrombosis/Pulmonary Embolism. January 2003 Diagnosis and Treatmentof Deep Venous thrombosis and Pulmonary Embolism Summary (Publication No. http://www.ahrq.gov/clinic/tp/dvttp.htm

Venous Thrombosis/Pulmonary Embolism January 2003 Clinical Focus* Treatment What are the efficacy and safety of low molecular weight heparin (LMWH) compared with unfractionated heparin (UFH) for the treatment of deep venous thrombosis (DVT)? What are the efficacy and safety of LMWH compared with UFH for treatment of pulmonary embolism (PE)? What are the efficacy and safety of outpatient versus inpatient treatment of DVT with LMWH or UFH? What is the cost-effectiveness of outpatient versus inpatient treatment of DVT with LMWH or UFH? What is the optimal duration of treatment for DVT and PE in patients without known thrombophilic disorders and in patients with thrombophilic disorders? The main outcomes of interest again were death, recurrent venous thromboembolism (VTE), and bleeding complications. Diagnosis How accurate are clinical prediction rules used for the diagnosis of DVT or PE? What are the test characteristics of ultrasonography for diagnosis of DVT? Are calf vein thromboses adequately identified with ultrasound? What are the test characteristics of helical computed tomography (CT) for diagnosis of PE relative to ventilation/perfusion (V/Q) scanning or standard angiography?

129. JAMA -- Abstract: Estrogen Plus Progestin And Risk Of Venous Thrombosis, October Results Venous thrombosis occurred in 167 women taking estrogen plus progestin Factor V Leiden enhanced the hormoneassociated risk of thrombosis with a http://jama.ama-assn.org/cgi/content/abstract/292/13/1573

Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery Student JAMA (1998-2004) JAMA CareerNet For The Media Meetings Peer Review Congress Vol. 292 No. 13, October 6, 2004 Featured Link E-mail Alerts Original Contribution Article Options Full text PDF Send to a Friend Related articles in this issue ... Similar articles in this journal Literature Track Add to File Drawer Download to Citation Manager PubMed citation Articles in PubMed by Cushman M for the Women's Health Initiative Investigators Articles that cite this article ISI Web of Science (19) ... Contact me when this article is cited Topic Collections Women's Health, Other Venous Thromboembolism Topic Collection Alerts Estrogen Plus Progestin and Risk of Venous Thrombosis Mary Cushman, MD, MSc Lewis H. Kuller, MD Ross Prentice, PhD Rebecca J. Rodabough, MS Bruce M. Psaty, MD, PhD Randall S. Stafford, MD, PhD Steven Sidney, MD Frits R. Rosendaal, MD, PhD JAMA.

130. MSRGSNet/Genetic Drift/Venous Thrombosis And The Factor V (Leiden) Mutation The other major genetic causes of venous thrombosis (deficiencies of protein C, Presence of the factor V mutation increases risk for venous thrombosis http://www.mostgene.org/gd/gdvol14b.htm

Previous Section This Issue- Table of Contents Next Section Vol. 14: Spring, 1997 Molecular Genetic Testing in Mainstream Medicine Venous Thrombosis and the Factor V (Leiden) Mutation Introduction Who should be tested? Deep vein thrombosis and pulmonary embolism Known genetic causes ... Illustrative case report Introduction Who should be tested? Indications include: Venous thrombosis or pulmonary embolism Transient ischemic attacks or premature stroke Peripheral vascular disease, particularly lower extremity occlusive disease History of a thrombotic event Family history of thrombosis or known factor V mutation in a relative Prior to major surgery, pregnancy, postpartum, oral contraceptive use or estrogen therapy if there is a personal or family history of thrombosis. Previous finding of activated protein C resistance by laboratory analysis Deep vein thrombosis and pulmonary embolism Venous thrombosis and pulmonary embolism pose a serious health problem. In this country half a million people are hospitalized each year and 50,000-100,000 deaths occur due to venous thrombosis which is also a leading cause of maternal death. The incidence of symptomatic venous thrombosis cases is approximately 1 in 1000 people per year. Venous thrombosis is a multifactorial condition caused by a combination of genetic, aquired or environmental influences. Natural anticoagulant systems (the protein C system and antithrombin III) are in place to keep coagulation in check. Excess clotting occurs when there is a disturbance in one of the coagulation inhibitor mechanisms or in natural lysis of clots.

131. SpringerLink - Publication ETRO WelcomeThe European thrombosis Research Organization (ETRO) is a non governmental,nonprofit organization open to every European laboratory or Institution doing http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0929-5305

132. Stents And Thrombosis [Apr 2002; 98-3] A monthly newsletter about evidencebased health care; top source for suchinformation on the net. http://www.jr2.ox.ac.uk/bandolier/band98/b98-3.html

@import "../styles/advanced.css"; Skip navigation Link to Back issues listing Back Issue Listing with content Index Subject Index Stents and thrombosis Study Results Comment Bandolier 92 reported a meta-analysis of trials looking at a comparison of stents versus balloon angioplasty indicating stents to be better. With stents the death rate was 3.8% and reinfarction rate 2.1% over six months in randomised trials up to 1999. The interesting question is whether this retrospective analysis represents what is happening in today's clinical practice, with technical advances and improved anticoagulation. An analysis of ongoing studies suggests that death and reinfarction rates are lower now than they were [1]. Study Six major clinical trials of coronary stenting were coordinated from Boston, all using similar inclusion criteria and protocols, but with different stents. Protocols used routine high-pressure postdilation, and with aspirin 325 mg daily and ticlopidine 250 mg twice daily for four weeks, but with glycoprotein IIb/IIIa inhibitors discouraged. All used stent thrombosis as a clinical endpoint, and with the same definition of clinical and angiographic stent thrombosis and myocardial infarction. From the paper it appears that some, but not all, of the trials were randomised.

133. Controversies In Pulmonary Embolism And Deep Venous Thrombosis - November 1, 199 Deep venous thrombosis and pulmonary embolism should be treated with Compared with pulmonary embolism, deep venous thrombosis (DVT) can be less http://www.aafp.org/afp/991101ap/1969.html

Advanced Search AAFP Home Page Journals Vol. 60/No. 7 (November 1, 1999) Controversies in Pulmonary Embolism and Deep Venous Thrombosis BRUCE L DAVIDSON, M.D., M.P.H., Virginia Mason Medical Center, Seattle, Washington F ew common medical conditions are as difficult to diagnose as pulmonary embolism. Treatment is usually satisfactory, but optimal treatment is controversial. An estimated 300,000 Americans suffer pulmonary embolism each year. Among those in whom the condition is diagnosed, 2 percent die within the first day and 10 percent have recurrent pulmonary embolism; the death rate among the latter group is 45 percent. Thus, suspicion of pulmonary embolism and its prevention are critically important, even while consensus on diagnosis and optimal treatment is not at hand. TABLE 1 Unsuspected Pulmonary Embolism as the Cause of Death in Two Hospital Autopsy Series Number of deaths (%) Hospital Pulmonary embolism caused death Pulmonary embolism unsuspected before autopsy St. Michael's Hospital, Universityof Toronto, Ontario (48 months)

134. Genomics|HuGENet™|Case Study|FVL|Overview Venous thrombosis is an important cause of morbidity; incidence is low in young In a small proportion of cases, venous thrombosis leads to pulmonary http://www.cdc.gov/genomics/hugenet/CaseStudy/FVL/FVLview.htm

home case study Archived: Dec. 2001 Factor V Leiden and Venous Thrombosis All case studies Summaries Bibliography Reader's Forum Educational Objectives After reading this case study you should be able to: identify key characteristics of the study population (cases and controls) that should be described when reporting results of gene-disease association studies. summarize gene-disease associations in terms of absolute, relative and attributable risks. discuss possible implications of the findings for researchers, people with Venous Thrombosis, and people with one or more of the newly described Factor V Leiden variants. Venous thrombosis is an important cause of morbidity; incidence is low in young people but increases with age to 1% per year in the elderly. In a small proportion of cases, venous thrombosis leads to pulmonary embolism, which can be fatal. Persons with an initial venous thrombosis are at increased risk for recurrence; however, long-term use of anticoagulant prophylaxis can result in major hemorrhagic complications. This challenging clinical problem has received new attention since the discovery of certain genetic variants that increase susceptibility to venous thrombosis. Under normal conditions, procoagulant and anticoagulant factors in the blood are in balance. However, persons with inherited alterations in proteins that promote or prevent coagulation may be predisposed to excessive bleeding (as in hemophilia) or clotting (thrombophilia). Persons with thrombophilia are at increased risk of developing clots that obstruct blood flow locally or that detach and embolize. Environmental factors that cause vascular injury (e.g., surgery), stasis (e.g., prolonged immobility), or increased coagulability (e.g., hormone use) interact with genetic susceptibility to increase the risk for thrombosis.

135. ISTH Homepage http://www.med.unc.edu/isth/welcome

136. ISTH Homepage http://www.med.unc.edu/isth/

137. CHRCARELINK Your Health Carelink Donations Opportunities. Your Health Topics. Search YourHealth Topics. Health Content. Age and Gender Groups http://yourhealth.calgaryhealthregion.ca/

Your Health Topics Search Your Health Topics Health Content Age and Gender Groups Health and Wellness Health Topics Tests and Procedures

138. Spotlight Health Join Spotlight Health s DVT community! Click here to register with us and subscribeto our DVT enewsletter. LOV-WS-3251-1. http://www.spotlighthealth.com/dvt/dvt/dvt.htm

139. Thromb J Volume 3;  2005 http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=207

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 7     121-139 of 139    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7